US Patent Issued to Emory University on March 25 for "Chimeric RSV, immunogenic compositions, and methods of use" (Georgia Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,296, issued on March 25, was assigned to Emory University (Atlanta).

"Chimeric RSV, immunogenic compositions, and methods of use" was invented by Martin L. Moore (Decatur, Ga.) and Christina Rostad (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to chimeric respiratory syncytial virus (RSV), live attenuated vaccine and immunogenic compositions, and methods of use. In certain embodiments, the chimeric respiratory syncytial virus has a mutated gene pattern encoding an RSV F protein having M at position 79, R at position 191, K at position 357, and/or Y at position 371."

The patent was filed on Jan. 14, 2022, under App...